FLGT — Fulgent Genetics Inc

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Fulgent Genetics Inc

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncol… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$17.67
Market Cap$484M
Float17.7M
Shares Outstanding28.4M
P/E (Forward)7.70
Price/Sales (TTM)1.51
vs. Analyst Target+4.7% to analyst PT
Profit Margin-23.04%
Operating Margin (TTM)-45.01%
Revenue (TTM)$320M
Earnings Growth (YoY)-98.60%
Dividend RateNone
Analyst Target Price$18.50 (3 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $422M $214M $332M $293M
2021 $993M $104M $777M $106M
2022 $619M $143M $367M $218M
2023 $289M -$168M $104M -$147M
2024 $283M -$42.7M $107M -$49.0M
2025 $323M -$60.5M $131M -$45.8M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $81.8M -$19.0M
Sep 2025 $84.1M -$6.6M
Dec 2025 $83.3M -$23.4M
Mar 2026 $71.1M -$24.8M

Ownership & Float

Insider Ownership36.7%
Institutional Ownership63.6%
Short Float14.1%
% of All Funds Holding1.73%
Number of Funds Holding142

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$16.00Near-term / short-term trend
Weekly40-Week SMA$21.88Medium-term trend
Weekly80-Week SMA$20.30Cyclical trend (business cycle)
Weekly200-Week SMA$25.94Secular trend (multi-year)
Monthly10-Month SMA$21.34Near-term monthly trend
Monthly20-Month SMA$19.79Medium-term monthly trend
Monthly40-Month SMA$23.56Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$14.10 support 1.35x 0 months ago
$26.20 resistance 1.20x 2 months ago

Historical Earnings Reactions (39 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.60% 0.09% 51.28% 31.96% -17.78%
1 Day -1.59% -1.10% 38.46% 38.40% -34.03%
1 Week 0.54% -2.94% 41.03% 45.32% -46.56%
2 Weeks 1.55% -1.52% 48.72% 48.23% -38.38%
1 Month 0.40% -1.51% 47.37% 60.82% -53.87%

Next earnings: July 20, 2026 (54 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan10.8%60.0%10
Feb-5.3%30.0%10
Mar-1.5%40.0%10
Apr1.4%30.0%10
May-0.0%44.4%9
Jun3.1%55.6%9
Jul11.2%66.7%9
Aug4.0%33.3%9
Sep-2.7%22.2%9
Oct-7.2%10.0%10
Nov9.7%60.0%10
Dec3.9%70.0%10

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.32% 50.3% 453
Tuesday -0.01% 47.9% 499
Wednesday 0.09% 48.2% 496
Thursday 0.23% 48.9% 487
Friday 0.08% 45.4% 489

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 63.6%

Insider Transactions — Smart Summary

Total insider ownership: 36.7%

Founder-led management: Ming Hsieh (Chairman & CEO), Hanlin Gao (Chief Scientific Officer & Lab Director)

12-Month Insider Activity Summary

Total Filings17
Net Value-$673,267.264
Net Shares Change-35,950
% of Float-0.2%
C-Suite Filings17
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Xie Jian President and COO -$430,063.899 6 6 sell
Gao Hanlin Chief Scientific Officer -$98,058.161 4 4 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-12-03 Xie Jian President and COO -$32,298.252 Transaction at $28.33, now -37.6%
2025-12-03 Gao Hanlin Chief Scientific Officer -$30,456.685 Transaction at $28.33, now -37.6%
2025-12-01 Xie Jian President and COO -$35,424.261 Transaction at $29.57, now -40.2%
2025-12-01 Gao Hanlin Chief Scientific Officer -$27,884.039 Transaction at $29.57, now -40.2%
2025-11-21 Xie Jian President and COO -$290,983 Transaction at $29.10, now -39.3%
2025-11-25 Xie Jian President and COO -$20,752.113 Transaction at $30.47, now -42.0%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Fulgent Genetics Inc (FLGT) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for FLGT on Trend Edge →